What’s new on emerging resistant Candida species

Absence of Azole or Echinocandin Resistance in Candida glabrata Isolates in India despite Background Prevalence of Strains with Defects in the DNA Mismatch Repair Pathway

(2018) Ashutosh Singh et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Understanding Echinocandin Resistance in the Emerging Pathogen Candida auris

(2018) Milena Kordalewska et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Candida auris: epidemiological situation, laboratory capacity and preparedness in European Union and European Economic Area countries, 2013 to 2017

(2018) Anke Kohlenberg et al.   Eurosurveillance

A multicentre study of antifungal susceptibility patterns among 350 Candida auris isolates (2009–17) in India: role of the ERG11 and FKS1 genes in azole and echinocandin resistance

(2018) Anuradha Chowdhary et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Evaluation of the efficacy of rezafungin, a novel echinocandin, in the treatment of disseminated Candida auris infection using an immunocompromised mouse model

(2018) Christopher L Hager et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Fungemia Surveillance in Denmark Demonstrates Emergence of Non-albicans Candida Species and Higher Antifungal Usage and Resistance Rates than in Other Nations

(2018) Mariana Castanheira   JOURNAL OF CLINICAL MICROBIOLOGY

Candida auris: Disinfectants and Implications for Infection Control

(2018) Tsun S. N. Ku et al.   Frontiers in Microbiology

Intensive care medicine research agenda on invasive fungal infection in critically ill patients

(2017) Matteo Bassetti et al.   INTENSIVE CARE MEDICINE

Multidrug-Resistant Candida: Epidemiology, Molecular Mechanisms, and Treatment

(2017) Maiken Cavling Arendrup et al.   JOURNAL OF INFECTIOUS DISEASES

Candida auris: A rapidly emerging cause of hospital-acquired multidrug-resistant fungal infections globally

(2017) Anuradha Chowdhary et al.   PLoS Pathogens

Simultaneous Emergence of Multidrug-ResistantCandida aurison 3 Continents Confirmed by Whole-Genome Sequencing and Epidemiological Analyses

(2016) Shawn R. Lockhart et al.   CLINICAL INFECTIOUS DISEASES

Echinocandin resistance and population structure of invasiveCandida glabrataisolates from two university hospitals in Germany and Austria

(2016) Ulrike Klotz et al.   MYCOSES

Fluconazole and Echinocandin Resistance of Candida glabrata Correlates Better with Antifungal Drug Exposure Rather than with MSH2 Mutator Genotype in a French Cohort of Patients Harboring Low Rates of Resistance

(2016) Sarah Dellière et al.   Frontiers in Microbiology

Echinocandin Resistance in Candida

(2015) David S. Perlin   CLINICAL INFECTIOUS DISEASES

Clinical perspectives on echinocandin resistance among Candida species

(2015) Ryan K. Shields et al.   CURRENT OPINION IN INFECTIOUS DISEASES

Antifungal Resistance to Fluconazole and Echinocandins Is Not Emerging in Yeast Isolates Causing Fungemia in a Spanish Tertiary Care Center

(2014) Laura Judith Marcos-Zambrano et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Role of FKS Mutations in Candida glabrata: MIC Values, Echinocandin Resistance, and Multidrug Resistance

(2014) Cau D. Pham et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Resistance of Candida spp. to antifungal drugs in the ICU: where are we now?

(2014) Danièle Maubon et al.   INTENSIVE CARE MEDICINE

Increasing Echinocandin Resistance in Candida glabrata: Clinical Failure Correlates With Presence of FKS Mutations and Elevated Minimum Inhibitory Concentrations

(2013) Barbara D. Alexander et al.   CLINICAL INFECTIOUS DISEASES

Frequency of Decreased Susceptibility and Resistance to Echinocandins among Fluconazole-Resistant Bloodstream Isolates of Candida glabrata

(2012) M. A. Pfaller et al.   JOURNAL OF CLINICAL MICROBIOLOGY